Associazione Nazionale Medici Cardiologi Ospedalieri

www.anmco.it

CONGRESS ABSTRACT

CONGRESS ABSTRACT

Categorie
Assessment of Cardiovascular System Functional State in Relation to Psychological Stress in Adolescents.
Anno:
2025
A collaborative project between the ABC Study on Heart Disease Foundation and Liceo Guglielmo Marconi. Introduction: Psychological stress is a well-documented risk factor for cardiovascular diseases. Adolescents, undergoing rapid physical and emotional development, are particularly susceptible to stress, making the assessment of its impact on their cardiovascular system crucial….
Leggi di più
Rate-related left bundle branch block in a highly active individual: a comprehensive workup provides an unexpected diagnosis
Anno:
2025
This case presents a 36-year-old healthy male who developed a rate-related left bundle branch block (LBBB) during a routine treadmill test for sports fitness. Despite a family history of ischemic heart disease and conduction abnormalities, the patient had no typical cardiovascular risk factors, was asymptomatic and had previously normal…
Leggi di più
EVALUATION OF DIAGNOSTIC ACCURACY OF EXTREME CARDIOVASCULAR RISK DEFINITIONS IN ACUTE CORONARY SYNDROME PATIENTS
Anno:
2025
Background: In 2022 the European Society of Cardiology published a consensus paper with six definitions of extreme cardiovascular (CV) risk. In secondary the gold standard is definition 2: two cardiovascular events within two years. Commonly used are also acute coronary syndrome (ACS) combined with peripheral or polyvascular disease (definition…
Leggi di più
THE LIPID-LOWERING EFFICACY OF A NUTRACEUTICAL COMBINATION INCLUDING LEUCOSELECT PHYTOSOME, RED RICE, POLICOSANOL AND FOLIC ACID IN DYSLIPIDAEMIA PATIENTS: REAL-WORLD INSIGHTS
Anno:
2025
Background: Cardiovascular disease is a global health concern and reducing plasma LDL-C levels is a major goal in cardiovascular prevention. Our study aimed to evaluate the effectiveness of a nutraceutical formulation including leucoselect® phytosome®, red yeast rice, policosanol and folic acid on LDL-c levels in patients at low cardiovascular risk…
Leggi di più
Unconventional risk factors in cardiovascular diseases: a population-based Italian cohort study
Anno:
2025
Background Despite significant progress in managing conventional cardiovascular (CV) risk factors, countless CV events still occur in individuals without overt traditional risks. This underscores the need for a more comprehensive understanding of non-traditional risk factors and a more effective integration of risk scoring systems into clinical practice. Methods This…
Leggi di più
FEMALE HEAVY SMOKERS WITH ATYPICAL CHEST PAIN AND NEGATIVE FUNCTIONAL TESTS: ARE WE UNDERESTIMATING THE RISK?
Anno:
2025
BACKGROUND. Women are generally considered at low risk for cardiovascular disease. This led to gender bias and udertreatment of female patients. Women were inadequately represented in clinical trials for a long time, so that scores used in clinical practice  may not be effective in assessing their risk. Moreover, in…
Leggi di più
Bridging Gender Gaps in Cardiovascular Risk Management: Evidence for Precision Medicine
Anno:
2025
Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, driven largely by modifiable risk factors. However, the impact and management of these risk factors vary significantly between men and women, often to the detriment of female patients. This systematic review explores these disparities, with a focus on innovative…
Leggi di più
USE OF BEMPEDOIC ACID IN CLINICAL PRACTICE IN CAMPANIA: PRELIMINARY RESULTS OF THE BEACON STUDY (BEMPEDOIC ACID IN CAMPANIA: OPTIMIZING NEED) INTRODUCTION
Anno:
2025
Background: The aim of the present study was to evaluate the profile of patients prescribed Bempedoic acid (BA) in outpatient clinical practice in the Campania Region; in addition, the efficacy, tolerability of the drug and therapeutic adherence in short-term follow-up were assessed. Methods: The BeACON (Bempedoic Acid in Campania:…
Leggi di più
BENEFITS OF BEMPEDOIC ACID TREATMENT IN CARDIOVASCULAR RISK PATIENTS: DATA FROM A SINGLE-CENTRE EXPERIENCE
Anno:
2025
Background: cardiovascular diseases (CVDs) remain the leading global cause of morbidity and mortality, driven by risk factors such as dyslipidemia, which needs effective lipid-lowering strategies. Bempedoic acid, a novel non-statin lipid-lowering agent, acts by inhibiting ATP citrate lyase, reducing low-density lipoprotein cholesterol (LDL-C) synthesis. Many clinical trials have demonstrated its…
Leggi di più
Hormonal therapy-induced severe dyslipidemia
Anno:
2025
Background: Apulatamide, a nonsteroidal androgen receptor inhibitor, and degarelix, a gonadotrophin releasing hormone antagonist, are used as hormonal therapies for advanced prostate cancer (aPC) treatment. However, they may increase the risk of cardio-metabolic diseases which are the main cause of non-cancer-related death in patients with PC. We report a…
Leggi di più

A.N.M.C.O. – Via La Marmora 36, 50121 Firenze (Italy) – Partita I.V.A. 05469530488 – Codice Fiscale 01301130488 – Privacy
www.anmco.it | segreteria@anmco.it

Cookie Policy Privacy Policy

Seguici su

Facebook Twitter Youtube Linkedin Instagram Telegram